Cutaneous Leishmaniasis Diagnostic Study

Status Completed

Clinical Trial Summary

The performance of the CL Detect Rapid test will be tested in individuals with suspected cutaneous leishmaniasis in Ethiopia using both skin slit and dental broach samples against a combined reference of microscopy and PCR. Alternative sampling methods will also be evaluated.

Clinical Trial Description

Cutaneous Leishmaniasis is common in Ethiopia and mainly affects the poor living in rural areas. Diagnosis of CL routinely uses invasive skin slits which are examined with microscopy, requiring trained staff and an equipped lab. A new rapid diagnostic test for CL which may be used in the field has been developed and validated in several countries where other Leishmania species are present. Less invasive tape sampling has also become available. Whether this new RDT and alternative sampling methods can be used in Ethiopia is unclear. The performance of the CL detect Rapid Test against a combined reference (microscopy and PCR) and alternative sample collection methods will be tested in CL suspected individuals in North-West Ethiopia in a cross-sectional study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03837431
Study type	Observational
Source	Institute of Tropical Medicine, Belgium
Contact
Status	Completed
Phase
Start date	February 13, 2019
Completion date	January 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT03292835` - Complex Cutaneous Leishmaniasis Healing Study in Algeria
Terminated	`NCT03208543` - Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan	Phase 3
Completed	`NCT04512742` - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies	N/A
Completed	`NCT04004754` - Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
Active, not recruiting	`NCT05332093` - Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
Active, not recruiting	`NCT04515186` - Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World	Phase 3
Completed	`NCT02919605` - Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis	Phase 2
Not yet recruiting	`NCT05493059` - Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
Terminated	`NCT04001335` - Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
Completed	`NCT03929016` - Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects	Phase 1
Completed	`NCT03435419` - Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan	N/A